Aura Biosciences Presents Interim Phase 1b/2 Data at the American Society of Retina Specialists (ASRS) Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura presented interim data from an open-label Phase 1b/2 study of light-activated AU-011 for the treatment of primary choroidal melanoma.